Mamantia, Rejane .
HRN: 23-58-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
CEFTAZIDIME 1GM (VIAL)
08/31/2023
09/26/2023
IV
36mg
Q12
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes